Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...

Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.

Family and gender-based violence can have lasting impacts on physical and mental health and be at the root of public health issues, such as substance use, suicide and self-harm, anxiety, depression ...

With new backing from AIX Ventures, Peter Thiel, and healthcare and AI pioneers, Ataraxis AI is positioned to rapidly bring its first offering, Ataraxis Breast, to market “This investment is a ...

Artificial intelligence is a big trend in cancer care, and it's mostly focused on detecting cancer at the earliest possible ...

That’s the problem Ataraxis AI is trying to solve. The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their cancer outcome ...

With new backing from AIX Ventures, Peter Thiel, and healthcare and AI pioneers, Ataraxis AI is positioned to rapidly bring its first offering, Ataraxis Breast, to market NEW YORK, March 05, ...